JBG Smith
JBG Smith trades at an estimated 40% discount to NAV, backed by National Landing multifamily assets, Amazon HQ demand and $1.3 billion of…
Search
Find coverage by company
Every article we have published, filed by the company it is actually about.
1933 articles about companies over $300M
catechwilliams on X
@Mike10947310 $CVGW Sources >90% of its avocados from Michoacan, MX. $CMG purchases ~10% of tot US avocados. Its latest ESG report noted “diversifying away from Mexican suppliers.” This latest drama down there will almost certainly accelerate sourcing away from $CVGW, etc.
catechwilliams on X
$CVGW Bloomberg: USDA halting avocado shipments from Michoacan, Mexico following threats to inspection officers. $CVGW Sources >90% of its avocado from Michoacan. Potentially related to FCPA investigation given agencies involved. https://t.co/j15wm3bbIa
catechwilliams on X
$CVGW Problems intensifying, another promised deadline passes. The RFG sale announced in Dec w CEO Cole stating “it will close within a month.” April AGM, he declared “I’m 100% sure it will close in May, likely sooner!” This guy has zero credibility and is borderline pathological https://t.co/Hg7gVfxeEF
Voss Capital on X
Here is a link to our Q1 2024 letter. https://t.co/mVYPJrgCr1 $SWI $IMXI $ALTG $GENI $RTO $RCM $SLCA @jonrice80 @taylor_hndrson
Little Owl Research on X
@ragingbullcap @PropertyBigE $SEG could get very interesting. It'll be well capitalized and the approval of 250 Water St. definately doesn't hurt. I still need to see the S-1 filing and terms for the offering before making any major decisions but they've piqued my interest.
MNST Trading Below $53 Offers Nearly Risk-Free Return
Monster Beverage’s modified Dutch auction lets odd-lot holders buy 99 MNST shares below $53 and tender them at $53 to $60.
catechwilliams on X
Meanwhile disintermediation by OEMs going direct is accelerating. See recent commentary from partners $CSCO, $PANW $DELL, etc. $PLUS has zero discernable benefit from $NVDA and AI.
catechwilliams on X
Answer: aggressive revenue booking, financing sales, selling products at/ below cost to boost revenue and hoping to “then try to build it back up over time” per CEO. Contrast $PLUS performance w competitor and industry leader $CDW.
catechwilliams on X
$PLUS Numbers don’t add up. 50% sales $CSCO product (sales -13% MRQ, guided -11%). MRQ $PLUS sales +13% (reported yesterday). Earnings call question: “OEM Cisco have talked about bottlenecks, weak orders. You’ve been unscathed…how are you outperforming the market significantly?”
catechwilliams on X
$EXLS Highly innovative founder-CEO rapidly taking share w AI-based services. High-teens topline growth w expanding margins, higher value-add mix to attractive end-markets. 17x P/E yet to reflect business transformation. 100% FCF to buybacks. Winning customers from $ACN $DXC $WIT
Some Thoughts on Roaring Kitty
Roaring Kitty’s GameStop resurgence revisits GME shareholder activism and the meme-stock trading episode, with references to Bed Bath &…
(I)nbound (M)igrants (X)panding (I)nternational Remittances
International Money Express trades at roughly 5x forward EV/EBITDA despite growth, modest leverage and excess cash available for…
Little Owl Research on X
8/ There is a lot more to talk about (24% sequential increase in new home sales, ward village condo sales etc.) but I am hungry. So to wrap up, if you're selling $HHH on this quarterly report you do not understand what you own and I will be buying your shares at tomorrow's open.
Little Owl Research on X
1/ So first things first, $HHH missed on top and bottom line. Am I concerned? Absolutely not. Value was created for shareholders and I'll briefly explain why...
catechwilliams on X
$OII Niche leader in subsea robotics at 12x P/E. Offshore rig count accelerating (70% share), A&D growing DD, new autonomous tech a major growth driver in other end markets (lifts, etc). Investor day next week will showcase products and new LT targets. >50% NTM upside, IMO.
(C)riminally (V)alued (S)caled Healthcare Services
CVS Health fell 20% after cutting 2024 adjusted EPS guidance to $7, but its Aetna insurance and Caremark PBM businesses support a…
Alta Fox REVG Presentation
Alta Fox presents on REV Group at BTIG’s Best Ideas event in Omaha.
catechwilliams on X
@TheMuffinMan28 SRS is a PE rollout, bit of a hodgepodge of assets. Concentration in landscaping, pool and roofing. No exclusive relationships (GMS is for $AWI, regional duopoly across most categories). End customers are small homebuilders (more competitive, less scale benefit for distributors).
catechwilliams on X
$GMS Underfollowed building products distributor, HSD growth, favorable mix shift/ margin, tracking to beat estimates, trading at 10x EPS, 7x EBITDA. Peers at >50% higher multiples. $HD just acquired lower quality peer SRS for 17x EBITDA. GMS = $240 or +150% at that multiple.
catechwilliams on X
$CVGW Situation getting : 1) being investigated by SEC, DOJ for bribery, cartel dealings, 2) intensely competitive biz, losing customers/ share w zero earnings; 3) sale of struggling prepared segment faltering. None of this is priced-in yet. Next 2 quarters likely a disaster.
catechwilliams on X
$LYTS Very attractive acq of EMI following successful prior M&A blueprint--significant cross-selling op, cost reduction, expands product set which further solidifies dominant national position. Seeing +50% upside to shares from here.
Little Owl Research on X
@Tonyforever2003 @marketplunger1 This is exactly what came to my mind when reading this. I'm long $GPRK and $GTE for precisely this reason.
Little Owl Research on X
Here is a little pricing guide for any of you looking into $HHH at the moment. Credit to @mfwarder for the format. https://t.co/MeZP5qopmR
